Neochord Product Sheet

Listing Results Neochord Product Sheet

About 19 results and 4 answers.

Home NeoChord

NeoChord ConsultConnect and ConnectCARD is a medical consultation and service related to delivery of artificial chordae tendineae for treatment of mitral insufficiency. The NeoChord Artificial Chordae Delivery System, Model DS1000 , meets the essential requirements referred to in Article 3 of the MDD 93/42/EEC and is labeled with the CE marking ...

Show more

See More

NeoChord Minimally Invasive Mitral Valve Repair Mitral

Aug 14, 2018 . The NeoChord device, in illustration, is inserted in the beating heart through a small incision, guided by echocardiography “While the heart is beating, you make a small incision under the patient’s left nipple, insert the device, and implant the artificial chords to the mitral valve,” says Dr. El-Eshmawi, the site Principal Investigator for the study.

Show more

See More

News NeoChord

NeoChord ConsultConnect and ConnectCARD is a medical consultation and service related to delivery of artificial chordae tendineae for treatment of mitral insufficiency.The NeoChord Artificial Chordae Delivery System, Model DS1000, meets the essential requirements referred to in Article 3 of the MDD 93/42/EEC and is labeled with the CE marking of conformity.

Show more

See More

NeoChord Announces Positive 30-day Results with

The company’s commercially available product, the NeoChord Artificial Chordae Delivery System DS1000, received CE market clearance in December 2012 and has treated more than 1,700 patients ...

Show more

See More

Contact Us NeoChord

NeoChord ConsultConnect and ConnectCARD is a medical consultation and service related to delivery of artificial chordae tendineae for treatment of mitral insufficiency.The NeoChord Artificial Chordae Delivery System, Model DS1000, meets the essential requirements referred to in Article 3 of the MDD 93/42/EEC and is labeled with the CE marking of conformity.

Show more

See More

Myxomatous Mitral Valve Repair Loop Neochord Technique

The loop NeoChord technique provides a versatile and reproducible method that can be used for anterior, posterior, or bileaflet prolapse, as well as Barlow’s disease. Preoperative planning and careful intraoperative valvular assessment are used to determine the appropriate loop length. Prefabricated commercial

Show more

See More

NeoChord Mitral Valve Repair Device

Jan 08, 2013 . Tech Update: NeoChord Mitral Valve Repair Device Gets CE Mark. By Adam Pick on January 8, 2013. As we continue to monitor the newest technologies enhancing valvular therapy, I though you might like to know that the NeoChord mitral valve repair system recently received a CE mark for use in Europe. This unique device, which is not FDA approved in ...

Show more

See More

NeoChord - Crunchbase Company Profile & Funding

NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chest

Show more

See More

neoChord DS1000 - YouTube

Oct 16, 2009 . Digital animation of beating-heart, sternal-sparing implantation of artificial chordae tendineae enabled by NeoChord's surgical device -- a minimally-invasiv...

Show more

See More

About Us NeoChord

NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

Show more

See More

Google Sheets: Sign-in

Access Google Sheets with a free Google account (for personal use) or Google Workspace account (for business use).
NeoChord

Show more

See More

NeoChord Announces $25 Million Series D Financing to

Nov 05, 2018 . The NeoChord procedure is a beating heart, echo-guided treatment option for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. In standard...

Show more

See More

NeoChord, Inc. LinkedIn

The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012. LinkedIn. NeoChord, Inc. in Worldwide Expand search.

Show more

See More

Jennifer Donovan - Director, Operations - NeoChord, Inc

NeoChord, Inc. is a global medical technology company leading the advancement of beating heart mitral valve repair for patients with degenerative mitral valve regurgitation. ...
Title: Director, Operations at …
Location: Minneapolis, Minnesota, United States
500+ connections

Show more

See More

Mitral valve repair using adjustable posterior leaflet

Mitral valve regurgitation (MR) is a common disorder1 that has been found to be a powerful predictor of serious morbidity and mortality.2 As such, the management of MR has evolved over time and has trended toward a more aggressive surgical approach to mitral valve pathology.3, 4 This trend is likely a product of the appreciation of the risks associated with untreated MR but …

Show more

See More

Frequently Asked Questions

  • What is neoneochord?

    NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

  • What is neochord artificial chordae delivery?

    The NeoChord Artificial Chordae Delivery System is a beating heart procedure, echo-guided treatment option for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. This opens in a new window.

  • What is neochord mitral valve repair device?

    Tech Update: NeoChord Mitral Valve Repair Device Gets CE Mark. This unique device, which is not FDA approved in America, enables minimally invasive implantation of artificial chordae using a catheter-based approach. If you did not know, the chordae support the mitral valve leaflets as they open-and-close to move the blood through your heart.

  • Is there a clinical trial for neochord DS1000?

    A clinical study is ongoing within the United States to evaluate the use of the NeoChord DS1000. Mount Sinai Heart is leading a multicenter clinical trial of a minimally invasive mitral valve prolapse repair technology that has the potential to transform the standard of care for the disorder.

Have feedback?

If you have any questions, please do not hesitate to ask us.